Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Jonuleit

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Methods in Molecular Medicine|December 9, 2004
Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cellsHelmut Jonuleit, Edgar Schmitt
Plos One|September 7, 2012
Plasmacytoid dendritic cells are inefficient in activation of human regulatory T cellsMario Hubo, Helmut Jonuleit
Transplantation|January 17, 2004
Human CD(4+)CD(25+) regulatory T cells and infectious toleranceMichael Stassen, Edgar Schmitt, Helmut Jonuleit
Nanomedicine (London, England)|September 23, 2016
Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapyHelmut Jonuleit, Tobias Bopp, Christian Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2010
Research in practice: Regulatory T cells - targets for therapeutic approaches?Helmut Jonuleit, Andrea Tuettenberg, Kerstin Steinbrink, et al.
Frontiers in Immunology|June 22, 2012
Boosting regulatory T cell function by CD4 stimulation enters the clinicChristian Becker, Tobias Bopp, Helmut Jonuleit
Transplant Immunology|September 12, 2003
Immune regulation by regulatory T cells: implications for transplantationHelmut Jonuleit, Gosse Adema, Edgar Schmitt
Annals of Medicine|August 19, 2007
Regulatory T cells--the renaissance of the suppressor T cellsTobias Bopp, Helmut Jonuleit, Edgar Schmitt
European Journal of Immunology|April 11, 2012
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosisCatharina C Gross, Helmut Jonuleit, Heinz Wiendl
International Journal of Molecular Sciences|January 31, 2017
Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T CellsJanine Schlöder, Carsten Berges, Felix Luessi, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Methods in Molecular Medicine|December 9, 2004
Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cellsHelmut Jonuleit, Edgar Schmitt
Plos One|September 7, 2012
Plasmacytoid dendritic cells are inefficient in activation of human regulatory T cellsMario Hubo, Helmut Jonuleit
Transplantation|January 17, 2004
Human CD(4+)CD(25+) regulatory T cells and infectious toleranceMichael Stassen, Edgar Schmitt, Helmut Jonuleit
Nanomedicine (London, England)|September 23, 2016
Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapyHelmut Jonuleit, Tobias Bopp, Christian Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2010
Research in practice: Regulatory T cells - targets for therapeutic approaches?Helmut Jonuleit, Andrea Tuettenberg, Kerstin Steinbrink, et al.
Frontiers in Immunology|June 22, 2012
Boosting regulatory T cell function by CD4 stimulation enters the clinicChristian Becker, Tobias Bopp, Helmut Jonuleit
Transplant Immunology|September 12, 2003
Immune regulation by regulatory T cells: implications for transplantationHelmut Jonuleit, Gosse Adema, Edgar Schmitt
Annals of Medicine|August 19, 2007
Regulatory T cells--the renaissance of the suppressor T cellsTobias Bopp, Helmut Jonuleit, Edgar Schmitt
European Journal of Immunology|April 11, 2012
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosisCatharina C Gross, Helmut Jonuleit, Heinz Wiendl
International Journal of Molecular Sciences|January 31, 2017
Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T CellsJanine Schlöder, Carsten Berges, Felix Luessi, et al.
Pageof 7